(PharmaNewsWire.Com, July 16, 2021 ) According to the new market research report Sternal Closure Devices Market is estimated to be valued at USD 2.02 billion in 2018 and is projected to reach USD 2.61 billion by 2023, at a CAGR of 5.2%.
Growing availability of medical reimbursements across major markets, technological advancements in sternotomy techniques, and increased target patient population with the subsequent increase in the number of surgical procedures are expected to drive the demand for sternal closure systems during the study period.
The report covers the sternal closure systems market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2017. The presence of a large patient population accompanied by a well established medical reimbursement policy is expected to drive the growth of this region.
Based on procedure, the median sternotomy segment is estimated to be the largest segment of the market in 2018
The sternal closure systems market is segmented by procedure into median sternotomy, hemisternotomy, and bilateral thoracosternotomy. The median sternotomy segment is expected to account for the largest share of the sternal closure devices market in 2018, owing to rising number of critical patients suffering from cardiovascular diseases.
Based on material, the titanium material segment is expected to register the fastest growth rate in the forecast period
Based on material, the sternal closure devices market for closure devices is classified into stainless steel, PEEK, and titanium products. The titanium products segment is expected to grow at the highest CAGR during the forecast period.
This can be attributed to the increased market focus on titanium products due to the associated advantages and economies-of-scale, growing number of clinical research studies to evaluate the clinical efficacy of these products during sternal closure, and increased commercialization of titanium-based sternal closure systems across developed countries.
Based on product, the closure devices segment is expected to register the highest growth rate during the forecast period
Based on product, the sternal closure systems market is divided into closure devices and bone cement. Among these segments, closure devices are expected to grow at the highest CAGR during the forecast period. Factors such as increasing number of complex cardiovascular surgeries and growing availability of medical reimbursements across developed markets are expected to drive the growth of the closure devices segment in the next five years.
As of 2017, the major players in the sternal closure devices market are DePuy Synthes (US), A&E Medical (US) and Zimmer Biomet Holdings (US). Other players in this market include KLS Martin Group (US), Acute Innovations (US), Kinamed Incorporated (US), Orthofix International N.V. (US), ABYRX (US), Praesidia Srl (Italy), and IDEAR S.R.L. (Argentina) among others.
Available Customizations-
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographic Analysis-
> Further breakdown of the RoW sternal closure systems market into Latin America, the Middle East, and Africa
Product Analysis-
> Product matrix which gives a detailed comparison of the product portfolios of the top five companies
Company Information-
> Detailed analysis and profiling of additional market players (Up to 5)
Contact: Mr. Aashish Mehra MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 sales@marketsandmarkets.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
